South Africa medicine expenditure increases
Medicine expenditure among private health care members has increased for the first time since 2011, according to the latest Mediscor Medicine Review results released on Wednesday.
Mediscor PBM managing director Christo Rademan said medicine expenditure increased by 1.9% last year.
The pharmaceutical benefit management company examined and analysed medicine use among around 1.7 million private health care members in 2013.
Lordina Foundation Joins Help Africa On Medical Mission
The First Lady Mrs. Lordin Mahama has restated her commitment to improve the quality of health care delivery in the country. In a message delivered on her behalf at a health screening at the Gambaga witches camp in the Northern region, Mrs. Mahama said it is important for all to support the vulnerable in society since they can only contribute to the socio economic development of the country I they are strong and healthy.
Read more: Lordina Foundation Joins Help Africa On Medical Mission
Medical tablet could connect cardiology patients with doctors in Africa
Mobile technologies are rapidly being applied to the healthcare setting, but a recent development in Cameroon is thought to be a first “medical tablet” on the African continent.
Arthur Zang, a 26-year-old inventor, has come up with the Cardio Pad, which is being tested in the small village of Mbankomo outside of Cameroon’s capital, Yaoundé.
Zang tells the website How We Made it in Africa that the tablet, which permits healthcare workers in remote areas to perform cardiac tests, could fill a huge void – Cameroon has fewer than 50 cardiologists for more than 20 million people, he says, all of whom are located in the bigger cities and their hospitals.
Read more: Medical tablet could connect cardiology patients with doctors in Africa
Cipla to acquire majority stake in UAE-based pharma manufacturer for $21M
Mumbai-based drugmaker Cipla Ltd is acquiring 51 per cent stake in a UAE-based pharmaceutical company which has manufacturing and distribution business in Yemen for $21 million.
“Given the recent preference to local manufacturing, this secures the company’s presence in a fast growing market,” the company said in a stock exchange announcement.
At present Cipla has over 200 products in Yemen market. The company will pay $21 million for this transaction with additional considerations which would be paid over three years on achievement of milestones.
Read more: Cipla to acquire majority stake in UAE-based pharma manufacturer for $21M
